Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer

NCT04163237 is registered in ClinicalTrials.gov with Guangxi Medical University as lead sponsor.

NCT NCT04163237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04163237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer
Lead sponsor
Guangxi Medical University
Phase
Phase 3
Overall status
Unknown status
Start date
December 1, 2019
Completion date
November 30, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced liver cancer